期刊文献+

ERK1/2MAPK通路在Eca109细胞体外增殖和迁移中的作用及其机制 被引量:8

The role and mechanism of ERK1/2 MPAK pathway in proliferation and migration of Eca109 cell line in vitro
暂未订购
导出
摘要 目的观察ERK1/2 MAPK通路在食管鳞状细胞癌(ESCC)Eca109细胞系增殖和迁移中的作用并探讨其作用机制。方法使用MAPK(ERK1/2)抑制剂U0126处理Eca109细胞;细胞计数检测细胞增殖;倒置显微镜下观察细胞形态;实时荧光定量PCR(qRT-PCR)检测ERK1/2 mRNA;Western blot检测总ERK1/2(t-ERK1/2)和磷酸化ERK1/2(p-ERK1/2);MTT和细胞划痕实验检测细胞增殖和迁移能力;qRT-PCR检测MicroRNA-21(miR-21)。结果20μmol/L浓度的U0126可抑制Eca109细胞生长(P<0.05),破坏细胞正常形态,ERK1/2 MAPK通路的活化在蛋白质水平被抑制(P<0.05),Eca109细胞增殖和迁移明显减弱(P<0.05),显著下调miR-21的表达(P<0.05)。结论ERK1/2 MAPK信号通路抑制可减弱Eca109细胞增殖和迁移,其可能的作用机制之一与其抑制miR-21表达有关。 Objective To investigate and migration of Ecal09 cell line in the role and mechanism of ERK1/2 MPAK pathway in regulating proliferation vitro. Methods We treated Ecal09 cells with MAPK(ERK1/2)inhibitor (U0126) ; cell counting method detected the cell proliferation; Cell morphology was observed under inverted micro scope ;qRT-PCR detected ERK1/2 mRNA level; Western blot determined the expression of ERK1/2 protein level; MTI' and Wound scratch assay detected cell proliferation and migration; qRT-PCR examined miR-21 expression. Results Cell growth was inhibited by U0126 at 20 p, mol/L doses(P 〈0. 05) , destroyed the normal cell morpholo gy; inaetivited ERK1/2 MPAK pathway at protein level(P 〈 0. 05); inhibition of ERK1/2 MPAK pathway re- pressed cell proliferation and migration of Ecal09 cells and downregulated the expression of miR-21 ( P 〈 0.05 ). Conclusions Inhibition of ERK1/2 MPAK pathway inhibits proliferation and migration of Ecal09 cells, one of the most possible mechanism is associated it's effect on miR-21 expression.
出处 《基础医学与临床》 CSCD 北大核心 2014年第3期345-349,共5页 Basic and Clinical Medicine
基金 新疆自治区科技厅面上项目(2012211A080)
关键词 ERK1/2 ECA109细胞 增殖 迁移 MicroRNA-21 ERK1/2 Ecal09 cell proliferation migration MicroRNA-21
  • 相关文献

参考文献10

  • 1Parkin DM,Bray F,Ferlay J. Estimating the world cancer burden:Globocan 2000[J].International Journal of Cancer,2001.153-156.
  • 2Ekman S,Dreilich M,Lennartsson J. Esopha-geal cancer:current and emerging therapy modalities[J].EXPERT REVIEW OF ANTICANCER THERAPY,2008.1433-1448.
  • 3González Ortiz D1,Taro DH. Esophageal cancer subtypes and survival rates at the VA Caribbean Healthcare System:a 10-year experience[J].Bol Asoc Med P R,2009.14-17.
  • 4Whitmarsh AJ,Davis RJ. Transcription factor AP-1 regulation bymitogen-activated protien kinase signal transduction pathway[J].Molecular Medicine,1996.589-607.
  • 5Lim SC,Duong HQ,Parajuli KR. Pro-apoptotic role of the MEK/ERK pathway in ursode-oxycholic acid-induced apoptosis in SNU601 gastric cancer cells[J].Oncology Reports,2012.1429-1434.
  • 6Ling M,Li Y,Xu Y. Regulation of miRNA-21 by reactive oxygen species-activated ERK/NF-κB in arseniteinduced cell transformation[J].Free Radical Biology and Medicine,2012.1508-1518.
  • 7Huang TH,Wu F,Loeb GB. Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion[J].Journal of Biological Chemistry,2009.18515-18524.
  • 8Yamanaka S,Olaru AV,An F. MicroRNA-21 inhibits Serpinil,a gene with novel tumour suppressive effects in gastric cancer[J].Digestive and Liver Disease,2012.589-596.
  • 9Faltejskova P,Besse A,Sevcikova S. Clinical correlations of miR-21 expression in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cells[J].International Journal of Colorectal Disease,2012.1401-1408.
  • 10Moriyama T,Ohuchida K,Mizumoto K. MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation,invasion,and chemoresistance[J].Molecular Cancer Therapautics,2009.1067-1074.

同被引文献80

引证文献8

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部